Laserfiche WebLink
subparagraph 8(e)(ii), Subgrantor shall, after consideration of <br />Subgrantee's submission, accordingly issue a revised Notice of <br />Disallowed Costs, if any, no later than forty (40) days after <br />receipt of Subgrantee's information or documentation. <br />Subgrantee shall have ten (10) days from receipt of such Notice <br />to tender payment or a repayment plan acceptable to <br />Subgrantor; <br />iv. All statements, notices, responses and demands issued in <br />accordance with this paragraph shall be in writing and delivered <br />in accordance with the terms stated under this Agreement; and <br />v. Subgrantor may, at its discretion, reasonably extend the time <br />periods allowed for responses specified in this paragraph. <br />f. In the event that Subgrantee fails to comply with the audit <br />requirements stated herein, Subgrantor may impose sanctions as <br />provided in 2 CFR §200.338 - Remedies for noncompliance, which <br />may include: <br />i. Temporarily withholding cash payments pending correction of <br />the deficiency or more severe enforcement action by the <br />Federal awarding agency or Subgrantor; <br />ii. Disallowing all or part of the cost of the activity or action not in <br />compliance; <br />iii. Wholly or partly suspending or terminating the Grant; <br />iv, Initiate suspension or debarment proceedings (as authorized <br />under 2 CFR part 180 and Federal awarding agency <br />regulations); <br />v. Withholding further funding for the Grant; and /or <br />vi. Taking other remedies that may be legally available. <br />9. General Requirements <br />a. Travel Cost <br />In accordance with HHS Grants Policy Statement, travel costs are only <br />allowable where such travel will provide direct benefit to the project or <br />program. There must be a direct benefit imparted on behalf of the <br />traveler as it applies to the approved activities of the NOA. To prevent <br />disallowance of cost, the Subgrantee is responsible for ensuring that <br />only allowable travel reimbursements are applied in accordance with <br />their organization's established travel policies and procedures. <br />PICH Subcontract Page 14 <br />CFDA Number: 93.331 <br />Federal Award Identification Number (FAIN): U58DP005861 <br />Grant Number: 1U58DP005861 -01 <br />Funding Opportunity Announcement Number: CDC- RFA -DP14 -1417 <br />20A -16 <br />